Cargando…

Prognosis prediction and risk factors for triple‐negative breast cancer patients with brain metastasis: A population‐based study

BACKGROUND: Brain metastasis (BM) in triple‐negative breast cancer (TNBC) patients is associated with significant morbidity and mortality. In this research we aimed to develop a nomogram to predict the prognosis of TNBC patients with BMs (TNBC‐BM) and explore the potential risk factors. METHODS: We...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Yuqin, Zhang, Liguo, Tian, Wenjing, Li, Yijie, Qin, Qi, Mao, Yinyan, Liu, Xiuling, Hong, Jiawei, Hu, Lingzhi, Zeng, Qing’an, Zhang, Qingling, Zhao, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	RESEARCH ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134296/ https://www.ncbi.nlm.nih.gov/pubmed/36629093 http://dx.doi.org/10.1002/cam4.5575

Ejemplares similares

Vimentin and tumor–stroma ratio for neoadjuvant chemoradiotherapy response prediction in locally advanced rectal cancer
por: Tian, Wenjing, et al.
Publicado: (2022)

Role of ICAM1 in tumor immunity and prognosis of triple-negative breast cancer
por: Zhou, Qin, et al.
Publicado: (2023)

T-cadherin is associated with prognosis in triple-negative breast cancer
por: Kong, De-Di, et al.
Publicado: (2017)

Identification of potential key genes and pathways predicting pathogenesis and prognosis for triple-negative breast cancer
por: Lv, Xuemei, et al.
Publicado: (2019)

Characteristics of recurrence, predictors for relapse and prognosis of rapid relapse triple-negative breast cancer
por: Cai, Shuang-Long, et al.
Publicado: (2023)

Biological and clinical significance of flap endonuclease-1 in triple-negative breast cancer: Support of metastasis and a poor prognosis
por: Xu, Lu, et al.
Publicado: (2020)

miR-3178 inhibits cell proliferation and metastasis by targeting Notch1 in triple-negative breast cancer
por: Kong, Peng, et al.
Publicado: (2018)

CIP4 promotes metastasis in triple-negative breast cancer and is associated with poor patient prognosis
por: Cerqueira, Otto L.D., et al.
Publicado: (2015)

The expressions of NEDD9 and E-cadherin correlate with metastasis and poor prognosis in triple-negative breast cancer patients
por: Li, Peng, et al.
Publicado: (2016)

Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer
por: Qiu, Jingdan, et al.
Publicado: (2016)

The role of BRCA status on prognosis in patients with triple-negative breast cancer
por: Xie, Yuxin, et al.
Publicado: (2017)

CPSF4 promotes triple negative breast cancer metastasis by upregulating MDM4
por: Lee, Kaping, et al.
Publicado: (2021)

MiR-183-5p Promotes Proliferation, Metastasis and Angiogenesis in Breast Cancer Cells through Negatively Regulating Four and a Half LIM Protein 1
por: Li, Yi, et al.
Publicado: (2020)

Corrigendum: MiR-183-5p Promotes Proliferation, Metastasis and Angiogenesis in Breast Cancer Cells through Negatively Regulating Four and a Half LIM Protein 1
por: Li, Yi, et al.
Publicado: (2020)

MicroRNA-582-5p promotes triple-negative breast cancer invasion and metastasis by antagonizing CMTM8
por: Zeng, Xue, et al.
Publicado: (2021)

Up-Regulation of RFC3 Promotes Triple Negative Breast Cancer Metastasis and is Associated With Poor Prognosis Via EMT
por: He, Zhen-Yu, et al.
Publicado: (2016)

Identification of Key Genes Affecting the Tumor Microenvironment and Prognosis of Triple-Negative Breast Cancer
por: Yi, Jiarong, et al.
Publicado: (2021)

Silencing Notch4 promotes tumorigenesis and inhibits metastasis of triple-negative breast cancer via Nanog and Cdc42
por: Tian, Yuan, et al.
Publicado: (2023)

Identification of Metastasis-Associated Genes in Triple-Negative Breast Cancer Using Weighted Gene Co-expression Network Analysis
por: Xie, Wenting, et al.
Publicado: (2020)

Collagen triple helix repeat containing-1 negatively regulated by microRNA-30c promotes cell proliferation and metastasis and indicates poor prognosis in breast cancer
por: Lai, Yuan-hui, et al.
Publicado: (2017)

COP1, the negative regulator of ETV1, influences prognosis in triple-negative breast cancer
por: Ouyang, Mao, et al.
Publicado: (2015)

TCOF1 upregulation in triple-negative breast cancer promotes stemness and tumour growth and correlates with poor prognosis
por: Hu, Jianyang, et al.
Publicado: (2021)

Diagnostic and Prognostic Nomograms for Lung Metastasis in Triple-Negative Breast Cancer
por: Wang, Jianguo, et al.
Publicado: (2022)

RPLP1 promotes tumor metastasis and is associated with a poor prognosis in triple-negative breast cancer patients
por: He, Zhixian, et al.
Publicado: (2018)

MicroRNAs in the prognosis of triple-negative breast cancer: A systematic review and meta-analysis
por: Lü, Lingshuang, et al.
Publicado: (2017)

Gastric Metastasis of Triple Negative Invasive Lobular Carcinoma
por: Geredeli, Caglayan, et al.
Publicado: (2015)

A novel model associated with tumor microenvironment on predicting prognosis and immunotherapy in triple negative breast cancer
por: Zhang, Juan, et al.
Publicado: (2023)

Cytokines secreted from adipose tissues mediate tumor proliferation and metastasis in triple negative breast cancer
por: Zhang, Kai, et al.
Publicado: (2022)

Clinical features and prognosis of triple-negative breast cancer
por: Sanz, M Izquierdo, et al.
Publicado: (2009)

Exosomal GPT2 derived from triple‐negative breast cancer cells promotes metastasis by activating BTRC
por: Cui, Mingqing, et al.
Publicado: (2023)

Endothelial Cells Potentially Participate in the Metastasis of Triple-Negative Breast Cancer
por: Ma, Yanfei, et al.
Publicado: (2022)

Pirfenidone suppressed triple‐negative breast cancer metastasis by inhibiting the activity of the TGF‐β/SMAD pathway
por: Luo, Daiqin, et al.
Publicado: (2023)

Enhanced Therapeutic Efficacy of Combining Losartan and Chemo-Immunotherapy for Triple Negative Breast Cancer
por: Zhao, Qing, et al.
Publicado: (2022)

Triple-negative breast cancer: current treatment strategies and factors of negative prognosis
por: Baranova, Anna, et al.
Publicado: (2022)

Impact of histotypes on preferential organ‐specific metastasis in triple‐negative breast cancer
por: Li, Yaming, et al.
Publicado: (2019)

Platinum-based chemotherapy in triple-negative breast cancer: A meta-analysis
por: LIU, MIAO, et al.
Publicado: (2013)

Increased Expression Levels of WAVE3 Are Associated with the Progression and Metastasis of Triple Negative Breast Cancer
por: Kulkarni, Swati, et al.
Publicado: (2012)

Syntelin inhibits triple-negative breast cancer cell proliferation and metastasis
por: Mullen, McKay, et al.
Publicado: (2021)

An EMT-Related Gene Signature to Predict the Prognosis of Triple-Negative Breast Cancer
por: Zhang, Bo, et al.
Publicado: (2023)

Rad51 supports triple negative breast cancer metastasis
por: Wiegmans, Adrian P, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gfpk5632jk8bv9i2pg1t7f98ks